Search Results - "Merrill, Peter"

INNOVATION BOXES: BEPS AND BEYOND by Merrill, Peter

“…Over the last 15 years, 16 countries have adopted intellectual property (IP) or patent box regimes, including three G7 countries. This paper explains the IP…”
Get full text

Rationale and design of a multicenter randomized clinical trial of vestibulodynia: understanding pathophysiology and determining appropriate treatments (vestibulodynia: UPDATe) by Carey, Erin T., Geller, Elizabeth J., Rapkin, Andrea, Farb, Debbie, Cutting, Haley, Akaninwor, Jasmyn, Stirling, Christopher, Bortsov, Andrey, McNulty, Steven, Merrill, Peter, Zakroysky, Pearl, DeLaRosa, Jesse, Luo, Sheng, Nackley, Andrea G.

“…Limited data are available to establish evidence-based management protocols for vestibulodynia (VBD), a chronic vulvar pain condition that affects…”
Get full text

Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation by Luo, Nancy, MD, Merrill, Peter, PhD, Parikh, Kishan S., MD, Whellan, David J., MD, MHS, Piña, Ileana L., MD, MPH, Fiuzat, Mona, PharmD, Kraus, William E., MD, Kitzman, Dalane W., MD, Keteyian, Steven J., PhD, O’Connor, Christopher M., MD, Mentz, Robert J., MD

“…Abstract Background The safety and efficacy of aerobic exercise in heart failure (HF) patients with atrial fibrillation (AF) has not been well evaluated…”
Get full text

Association between trace elements in the environment and stroke risk: The reasons for geographic and racial differences in stroke (REGARDS) study by Merrill, Peter D., Ampah, Steve B., He, Ka, Rembert, Nicole J., Brockman, John, Kleindorfer, Dawn, McClure, Leslie A.

“…The disparities in stroke mortality between blacks and whites, as well as the increased stroke mortality in the “stroke belt” have long been noted. The reasons…”
Get full text

Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort by Kiage, James N, Merrill, Peter D, Judd, Suzanne E, He, Ka, Lipworth, Loren, Cushman, Mary, Howard, Virginia J, Kabagambe, Edmond K

“…Background: Whether elevated intakes of trans fatty acids (TFAs) increase the risk of stroke remains unclear. Except for the Women's Health…”
Get full text

Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort by Kiage, James N, Merrill, Peter D, Robinson, Cody J, Cao, Yue, Malik, Talha A, Hundley, Barrett C, Lao, Ping, Judd, Suzanne E, Cushman, Mary, Howard, Virginia J, Kabagambe, Edmond K

“…Background: A high intake of trans fatty acids decreases HDL cholesterol and is associated with increased LDL cholesterol, inflammation, diabetes, cancer, and…”
Get full text

Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods by Merrill, Peter D, McClure, Leslie A

“…Noncompliance to treatment assignment is an inevitable occurrence in randomized clinical trials (RCTs). Intention to treat (ITT) is generally considered the…”
Get full text

Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial by Diamantidis, Clarissa J., Bosworth, Hayden B., Oakes, Megan M., Davenport, Clemontina A., Pendergast, Jane F., Patel, Sejal, Moaddeb, Jivan, Barnhart, Huiman X., Merrill, Peter D., Baloch, Khaula, Crowley, Matthew J., Patel, Uptal D.

“…Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease (ESKD) in the United States. Multiple risk factors contribute to DKD…”
Get full text

Corporate tax policy for the 21st century by Merrill, Peter R

“…This paper discusses three issues relating to corporate tax policy in the United States for the 21st century. First, the paper compares U.S. corporate tax…”
Get full text

Renal Outcomes in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) by BETHEL, M. ANGELYN, MENTZ, ROBERT J., MERRILL, PETER, BUSE, JOHN B., CHAN, JULIANA C., GOODMAN, SHAUN G., IQBAL, NAYYAR, JAKUBONIENE, NELI, KATONA, BRIAN G., LOKHNYGINA, YULIYA, LOPES, RENATO D., MAGGIONI, ALDO P., OHMAN, PETER K., POULTER, NEIL R., RAMACHANDRAN, AMBADY, TANKOVA, TSVETALINA, ZINMAN, BERNARD, HERNANDEZ, ADRIAN F., HOLMAN, RURY R.

“…Background: EXSCEL was a multinational, randomized, blinded, placebo-controlled, pragmatic CV outcome trial of once-weekly exenatide on the background of usual…”
Get full text

Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery by van Diepen, Sean, Merrill, Peter D., Carrier, Michel, Tardif, Jean-Claude, Podgoreanu, Mihai, Alexander, John H., Lopes, Renato D.

“…Myonecrosis after coronary artery bypass graft (CABG) surgery is associated with excess mortality. Tranexamic acid (TA), an anti-fibrinolytic agent, has been…”
Get full text

Rationale and design of "Hearts & Parks": study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesity by Armstrong, Sarah C, Windom, McAllister, Bihlmeyer, Nathan A, Li, Jennifer S, Shah, Svati H, Story, Mary, Zucker, Nancy, Kraus, William E, Pagidipati, Neha, Peterson, Eric, Wong, Charlene, Wiedemeier, Manuela, Sibley, Lauren, Berchuck, Samuel I, Merrill, Peter, Zizzi, Alexandra, Sarria, Charles, Dressman, Holly K, Rawls, John F, Skinner, Asheley C

“…The prevalence of child and adolescent obesity and severe obesity continues to increase despite decades of policy and research aimed at prevention. Obesity…”
Get full text

Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial by Mentz, Robert J, Bethel, M Angelyn, Merrill, Peter, Lokhnygina, Yuliya, Buse, John B, Chan, Juliana C, Felício, João S, Goodman, Shaun G, Choi, Jasmine, Gustavson, Stephanie M, Iqbal, Nayyar, Lopes, Renato D, Maggioni, Aldo P, Öhman, Peter, Pagidipati, Neha J, Poulter, Neil R, Ramachandran, Ambady, Reicher, Barry, Holman, Rury R, Hernandez, Adrian F

“…Background In the EXSCEL (Exenatide Study of Cardiovascular Event Lowering), exenatide once-weekly resulted in a nonsignificant reduction in major adverse…”
Get full text

Do It Right the Second Time: Benchmarking Best Practices in the Quality Change Process by Merrill, Peter

Get full text

Innovation Boxes: BEPS and Beyond by Merrill, Peter

“…Over the last 15 years, 16 countries have adopted intellectual property (IP) or patent box regimes, including three G7 countries. This paper explains the IP…”
Get full text

The Executive Guide to Innovation: Turning Good Ideas Into Great Results by Keathley, Jane, Merrill, Peter, Owens, Tracy

“…Is your organization's level of innovation where you think it should be today?Now is the time to shape your future through innovation management. This book…”
Get full text

TAXATION AND REGULATION OF THE FINANCIAL SECTOR . By RUUD DE MOOIJ and GAËTAN NICODÈME by Merrill, Peter

Get full text

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis by Bethel, M Angelyn, Patel, Rishi A, Merrill, Peter, Lokhnygina, Yuliya, Buse, John B, Mentz, Robert J, Pagidipati, Neha J, Chan, Juliana C, Gustavson, Stephanie M, Iqbal, Nayyar, Maggioni, Aldo P, Öhman, Peter, Poulter, Neil R, Ramachandran, Ambady, Zinman, Bernard, Hernandez, Adrian F, Holman, Rury R

“…Glucagon-like peptide-1 (GLP-1) receptor agonists are effective glucose-lowering drugs. Findings from cardiovascular outcome trials showed cardiovascular…”
Get full text

Aquatic veterinary medicine by Merrill, Peter L., Tepper, Julius, Walster, Christopher I., Palić, Dušan, Miller-Morgan, Timothy, Johnston, Colin J.

“…With increased global reliance on aquaculture production, improvements in diagnostic and surgical techniques for all aquatic species, both vertebrates and…”
Get full text

Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial by Bethel, M Angelyn, Mentz, Robert J, Merrill, Peter, Buse, John B, Chan, Juliana C, Goodman, Shaun G, Iqbal, Nayyar, Jakuboniene, Neli, Katona, Brian, Lokhnygina, Yuliya, Lopes, Renato D, Maggioni, Aldo P, Ohman, Peter, Tankova, Tsvetalina, Bakris, George L, Hernandez, Adrian F, Holman, Rury R

“…To evaluate the impact of once-weekly exenatide (EQW) on microvascular and cardiovascular (CV) outcomes by baseline renal function in the Exenatide Study of…”
Get full text